OBJECTIVE: To describe community pharmacists' perceptions on their current role in direct patient care services, an expanded role for pharmacists in providing patient care services, and changes needed to optimally use pharmacists' expertise to provide high-quality direct patient care services to people living with human immunodeficiency virus (HIV) infections. DESIGN: Cross-sectional study. SETTING: Four Midwestern cities in the United States in August through October 2009. PARTICIPANTS: 28 community-based pharmacists practicing in 17 pharmacies. INTERVENTIONS: Interviews. MAIN OUTCOME MEASURES: Opinions of participants about roles of specialty and nonspecialty pharmacists in caring for patients living with HIV infections. RESULTS: Pharmacists noted that although challenges in our health care system characterized by inaccessible health professionals presented opportunities for a greater pharmacist role, there were missed opportunities for greater level of patient care services in many community-based nonspecialty settings. Many pharmacists in semispecialty and nonspecialty pharmacies expressed a desire for an expanded role in patient care congruent with their pharmacy education and training. CONCLUSION: Structural-level policy changes needed to transform community-based pharmacy settings to patient-centered medical homes include recognizing pharmacists as important players in the multidisciplinary health care team, extending the health information exchange highway to include pharmacist-generated electronic therapeutic records, and realigning financial incentives. Comprehensive policy initiatives are needed to optimize the use of highly trained pharmacists in enhancing the quality of health care to an ever-growing number of Americans with chronic conditions who access care in community-based pharmacy settings.
OBJECTIVE: To describe community pharmacists' perceptions on their current role in direct patient care services, an expanded role for pharmacists in providing patient care services, and changes needed to optimally use pharmacists' expertise to provide high-quality direct patient care services to people living with human immunodeficiency virus (HIV) infections. DESIGN: Cross-sectional study. SETTING: Four Midwestern cities in the United States in August through October 2009. PARTICIPANTS: 28 community-based pharmacists practicing in 17 pharmacies. INTERVENTIONS: Interviews. MAIN OUTCOME MEASURES: Opinions of participants about roles of specialty and nonspecialty pharmacists in caring for patients living with HIV infections. RESULTS: Pharmacists noted that although challenges in our health care system characterized by inaccessible health professionals presented opportunities for a greater pharmacist role, there were missed opportunities for greater level of patient care services in many community-based nonspecialty settings. Many pharmacists in semispecialty and nonspecialty pharmacies expressed a desire for an expanded role in patient care congruent with their pharmacy education and training. CONCLUSION: Structural-level policy changes needed to transform community-based pharmacy settings to patient-centered medical homes include recognizing pharmacists as important players in the multidisciplinary health care team, extending the health information exchange highway to include pharmacist-generated electronic therapeutic records, and realigning financial incentives. Comprehensive policy initiatives are needed to optimize the use of highly trained pharmacists in enhancing the quality of health care to an ever-growing number of Americans with chronic conditions who access care in community-based pharmacy settings.
Authors: Marie A Chisholm-Burns; Joshua S Graff Zivin; Jeannie Kim Lee; Christina A Spivey; Marion Slack; Richard N Herrier; Elizabeth Hall-Lipsy; Ivo Abraham; John Palmer Journal: Am J Health Syst Pharm Date: 2010-10-01 Impact factor: 2.637
Authors: Jon C Schommer; Craig A Pedersen; Caroline A Gaither; William R Doucette; David H Kreling; David A Mott Journal: J Am Pharm Assoc (2003) Date: 2006 May-Jun
Authors: Ezekiel Emanuel; Neera Tanden; Stuart Altman; Scott Armstrong; Donald Berwick; François de Brantes; Maura Calsyn; Michael Chernew; John Colmers; David Cutler; Tom Daschle; Paul Egerman; Bob Kocher; Arnold Milstein; Emily Oshima Lee; John D Podesta; Uwe Reinhardt; Meredith Rosenthal; Joshua Sharfstein; Stephen Shortell; Andrew Stern; Peter R Orszag; Topher Spiro Journal: N Engl J Med Date: 2012-08-01 Impact factor: 91.245
Authors: Thomas J Dilworth; Pamela W Klein; Renée-Claude Mercier; Matthew E Borrego; Bernadette Jakeman; Steven D Pinkerton Journal: J Manag Care Spec Pharm Date: 2018-02